Savorease Therapeutic Foods
PrivateLast Round
Accelerator
May 26, 2022
Total Funding Raised
$5,000
Momentum Score
75 /100
Company Overview
Savorease Therapeutic Foods is a food products company that develops and provides dissolvable, solid supplement finger foods for individuals with dysphagia and other chewing or swallowing difficulties.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, E-commerce, D2C Brands
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Savorease Therapeutic Foods Comps
Public and private peers based on sector, stage, and business model.
Savorease Therapeutic Foods Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 26, 2022 |
Savorease Therapeutic Foods Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ideaship | Accelerator |
| GrowthX | Accelerator |
| Chemical Angel Network | Accelerator |
| Portland Seed Fund | Accelerator |
| Oregon Business Development Department | Grant |
| myFace | Grant |
| Built Oregon | Accelerator |
Savorease Therapeutic Foods Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Savorease Therapeutic Foods's valuation, stock price, and market status.